|
KYV-101 Clinical Trials
2 actively recruiting trials across 2 locations
Orange, California1 trial
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
University of California, Irvine
Phase 2/3
Denver, Colorado1 trial
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
University of Colorado, Denver
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.